A new clinical trial has shown promising safety and efficacy results for liraglutide in the treatment of Alzheimer’s disease.
BIG on MSNOpinion
10 extremely worrying statements from POTUS
At 79 years old, Donald Trump is the oldest person ever to be inaugurated president. Yes, that’s right: in a role almost ...
Newer research shows the risks and benefits depend heavily on timing, hormone type and how therapy is delivered.
Longtime Northern Life columnist Erna de Burger-Fex shares her feelings, and struggles, on becoming a caregiver for her ...
Medications like Ozempic mimic a naturally occurring hormone called glucagon-like peptide-1, or GLP-1, which helps regulate blood sugar and appetite. GLP-1 is primarily secreted from the intestines, ...
Animalogic on MSN
What happens when a crow faces questions designed for children
The video examines an unusual intelligence test comparing a crow’s problem-solving skills with those of a typical fifth ...
It's surprisingly simple but could offer crucial clues about how well you're doing. Plus, how to take charge if you don't pass.
ALS is a debilitating paralytic disease characterized as the death of upper and lower motor neurons. Fortunately, ALS is ...
The Alzheimer’s, Dementia and Parkinson’s (ADP) research team at Nottingham Trent University is working to combat the ...
In this webinar, Jonathan Schott and Alex Forrest-Hay will showcase how new biomarker assays for brain-derived pTau217 ...
News-Medical.Net on MSN
New rapid blood test enables early and accurate diagnosis of ALS
ALS is a debilitating paralytic disease characterized by the death of upper and lower motor neurons. Fortunately, ALS is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results